Fig. 1From: The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTsThe network of comparisons for the outcomes. The numbers on the arrows indicate the number of comparisons with placebo for each outcomeBack to article page